Business Description
Welcure Drugs & Pharmaceuticals Ltd
ISIN : INE331C01017
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.38 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.87 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 168.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.94 | |||||
9-Day RSI | 42.8 | |||||
14-Day RSI | 48.44 | |||||
6-1 Month Momentum % | 39.91 | |||||
12-1 Month Momentum % | 98.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.6 | |||||
Quick Ratio | 0.74 | |||||
Days Inventory | 2555 | |||||
Days Sales Outstanding | 493.22 | |||||
Days Payable | 2809.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 16.48 | |||||
Operating Margin % | 5.5 | |||||
Net Margin % | 5.89 | |||||
FCF Margin % | -0.52 | |||||
ROE % | 4.15 | |||||
ROA % | 1.59 | |||||
ROIC % | 3.54 | |||||
3-Year ROIIC % | -24.1 | |||||
ROC (Joel Greenblatt) % | 4.33 | |||||
ROCE % | 4.15 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 4786.93 | |||||
PS Ratio | 3.61 | |||||
PB Ratio | 0.87 | |||||
Price-to-Tangible-Book | 0.87 | |||||
EV-to-EBIT | 61.11 | |||||
EV-to-EBITDA | 59.72 | |||||
EV-to-Revenue | 3.6 | |||||
EV-to-FCF | -692.92 | |||||
Price-to-Projected-FCF | 13.62 | |||||
Price-to-Net-Current-Asset-Value | 0.88 | |||||
Earnings Yield (Greenblatt) % | 1.64 | |||||
FCF Yield % | -0.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Welcure Drugs & Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 245.5 | ||
EPS (TTM) (₹) | -0.113 | ||
Beta | 0.01 | ||
Volatility % | 67.75 | ||
14-Day RSI | 48.44 | ||
14-Day ATR (₹) | 0.631614 | ||
20-Day SMA (₹) | 12.488 | ||
12-1 Month Momentum % | 98.43 | ||
52-Week Range (₹) | 3.76 - 15.81 | ||
Shares Outstanding (Mil) | 79.36 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Welcure Drugs & Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Welcure Drugs & Pharmaceuticals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Welcure Drugs & Pharmaceuticals Ltd Frequently Asked Questions
What is Welcure Drugs & Pharmaceuticals Ltd(BOM:524661)'s stock price today?
When is next earnings date of Welcure Drugs & Pharmaceuticals Ltd(BOM:524661)?
Does Welcure Drugs & Pharmaceuticals Ltd(BOM:524661) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |